Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions

Abstract

Iron is an essential micronutrient with profound implications for human growth, neurodevelopment, and overall health. While significant attention has focused on iron status in infancy, emerging evidence highlights the continued importance of iron metabolism throughout childhood, adolescence, and beyond. This review synthesizes current knowledge on developmental iron biology beyond infancy, focusing on epidemiology, pathophysiology, risk factors, clinical manifestations, diagnostic approaches, management strategies, recent advances, and guideline-based recommendations. Clinicians must recognize the nuanced needs of developing individuals to optimize lifelong health outcomes.

Introduction

Iron is critical for oxygen transport, DNA synthesis, cellular respiration, and neurocognitive development. Although infancy is a period of rapid iron demand, subsequent life stages also pose unique challenges for iron homeostasis. Growth spurts, dietary transitions, menstruation, and increased physical activity during childhood and adolescence can all impact iron requirements and risk of deficiency. Inadequate attention to iron status beyond infancy may predispose to cognitive deficits, immune dysfunction, and suboptimal growth, underscoring the need for ongoing vigilance and evidence-based intervention across the pediatric age spectrum.

Epidemiology / Disease Burden

Iron deficiency (ID) remains the most prevalent micronutrient disorder worldwide, affecting an estimated 25–40% of children and adolescents globally. Prevalence rates vary by age, sex, geographic location, and socioeconomic status, with adolescent girls at particular risk due to menstruation and increased demands. In developed countries, the prevalence of iron deficiency anemia (IDA) in children aged 1–5 years is approximately 1–2%, but non-anemic iron deficiency is more common and often underrecognized. Among school-aged children and adolescents, IDA rates rise sharply with the onset of puberty, especially in females. Iron deficiency during these critical periods can have long-lasting effects on cognitive function and physical development.

Pathophysiology

Iron homeostasis is tightly regulated through absorption, transport, storage, and recycling. In childhood and adolescence, increased erythropoiesis, rapid tissue growth, and hormonal changes elevate iron requirements. Hepcidin, a hepatic peptide hormone, acts as the central regulator by inhibiting intestinal iron absorption and mobilization from stores. During rapid growth or in the presence of inflammation, hepcidin expression can become dysregulated, leading to functional iron deficiency even with adequate stores. Additionally, the developing brain is highly sensitive to iron status, with deficiency disrupting myelination, neurotransmitter synthesis, and synaptic plasticity.

Risk Factors

Several factors heighten the risk of iron deficiency beyond infancy. These include rapid linear growth (childhood and adolescence), female sex (due to menstrual blood loss), vegetarian or restrictive diets, low socioeconomic status, chronic inflammatory conditions (e.g., obesity, IBD), and increased physical activity (athletes). Special populations, such as those with malabsorption syndromes, chronic kidney disease, or frequent blood donors, also warrant closer monitoring. Recognizing these risk factors is essential for timely screening and intervention.

Clinical Features

Iron deficiency in older children and adolescents often presents insidiously. Symptoms may include fatigue, impaired concentration, pallor, and decreased exercise tolerance. Neurocognitive effects-such as reduced attention span, learning difficulties, and behavioral disturbances-are particularly concerning, as they may persist even after hematologic correction. Other findings can include glossitis, angular cheilitis, brittle nails, and pica. In severe cases, IDA can manifest with tachycardia, systolic murmurs, and delayed growth or pubertal development.

Diagnosis

Diagnosis of iron deficiency requires a combination of clinical assessment and laboratory testing. Initial studies include complete blood count (CBC), serum ferritin, transferrin saturation, and serum iron. Ferritin is the most sensitive marker of iron stores but is also an acute-phase reactant and may be elevated in inflammation. In such cases, additional markers, such as soluble transferrin receptor (sTfR) or reticulocyte hemoglobin content, can help clarify iron status. Assessment of dietary intake, growth parameters, and risk factors is also crucial in the diagnostic workup.

Treatment & Management

Management of iron deficiency includes dietary counseling and iron supplementation. Oral ferrous sulfate is the mainstay, with dosing tailored to age, severity, and tolerability. Recent data support the use of alternate-day dosing to improve absorption and reduce gastrointestinal side effects. In cases of severe anemia, malabsorption, or intolerance to oral therapy, intravenous iron formulations may be indicated. Addressing underlying causes-such as heavy menstrual bleeding or chronic disease-is vital for sustained remission. Follow-up assessment to document hematologic response and monitor for recurrence is recommended.

Recent Advances / Emerging Therapies

Recent advances include novel oral iron formulations with improved bioavailability and fewer side effects, such as ferric maltol and sucrosomial iron. Intravenous preparations, including ferric carboxymaltose and iron isomaltoside, allow for rapid repletion in selected cases. Advances in understanding hepcidin regulation have spurred interest in hepcidin antagonists and modulators as future therapeutic options. Ongoing research into the impact of iron status on neurodevelopment and immune function continues to shape clinical practice and screening recommendations.

Guideline Recommendations

Professional societies, including the American Academy of Pediatrics and the World Health Organization, recommend routine screening for iron deficiency in at-risk populations beyond infancy, particularly adolescent females. Guidelines emphasize the importance of dietary education, targeted supplementation, and individualized care. The integration of ferritin and sTfR testing in diagnostic algorithms is increasingly supported, especially in settings of inflammation. Regular re-evaluation and patient education are cornerstones of prevention and management.

Conclusion

Iron biology beyond infancy is complex, with significant implications for growth, cognitive development, and long-term health. Vigilant screening, evidence-based management, and ongoing research into novel therapies are essential to address the global burden of iron deficiency. Clinicians must remain attuned to evolving evidence and tailor interventions to the unique needs of developing individuals, ensuring optimal outcomes across the pediatric and adolescent lifespan.